Journal article

Viral-mediated gene therapy for the muscular dystrophies: Successes, limitations and recent advances

Guy L Odom, Paul Gregorevic, Jeffrey S Chamberlain

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | ELSEVIER | Published : 2007

Abstract

Much progress has been made over the past decade elucidating the molecular basis for a variety of muscular dystrophies (MDs). Accordingly, there are examples of mouse models of MD whose disease progression has been halted in large part with the use of viral vector technology. Even so, we must acknowledge significant limitations of present vector systems that must be overcome prior to successful treatment of humans with such approaches. This review will present a variety of viral-mediated therapeutic strategies aimed at counteracting the muscle-wasting symptoms associated with muscular dystrophy. We include viral vector systems used for muscle gene transfer, with a particular emphasis on aden..

View full abstract

University of Melbourne Researchers